Study of efficacy and safety of everolimus and letrozole in estrogen receptor positive HER2 negative metastatic or locally advanced breast cancer patients

Mise à jour : Il y a 5 ans
Référence : EUCTR2012-003065-17

Femme Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective is to estimate progression-free survival in patients treated with everolimus + letrozole in the first line metastatic setting.


Critère d'inclusion

  • Estrogen receptor positive metastatic breast cancer